Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Dietary and Microbial Metabolites in Pediatric Inflammatory Bowel Disease

EF 2018-19

Résumé
Inflammatory bowel diseases (IBD), including Crohn disease (CD) and ulcerative colitis, affect 1 in 150 Canadians; 25% of cases are diagnosed in children. IBD manifests with chronic gastrointestinal inflammation and altered microbial composition. Dietary changes impact IBD, including the pediatric CD therapy exclusive enteral nutrition (EEN), which entails exclusive intake of liquid meal-replacement, making adherence challenging. Predicting patient outcomes to EEN requires improved understanding of pathogenesis. Our study examines how intestinal microorganisms are involved in IBD development. We hypothesize that an altered intestinal microbiome in response to dietary or bacterial-secreted metabolites mediates patient response to dietary therapy. I will investigate whether previous diet is a valid predictor of EEN success, using metabolomics to develop biomarkers that will identify candidates for EEN success. Pilot analysis of pre-diagnosis food frequency questionnaire (FFQ) data shows that simple carbohydrates and processed meat are predictors of EEN failure and success, respectively. I will expand the analysis to a nation-wide FFQ database, and correlate results with stool microbiome analysis and metabolomics to identify potential mediators. Significantly altered metabolites will be assessed in vitro: gentamicin protection assays and immunofluorescent microscopy will identify effects on bacterial invasion, transepithelial electrical resistance will indicate epithelial barrier integrity changes, and qPCR with Western blotting and ELISA will determine human cell line inflammatory responses. Understanding diet and microbial interactions in pediatric IBD can guide novel therapies and facilitate identification of patients likely to respond to dietary therapies.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
406288
Name
Dijk Stephanie I
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Dietary and Microbial Metabolites in Pediatric Inflammatory Bowel Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Diet; Dietary Therapy; Food Frequency Data; Inflammation; Inflammatory Bowel Diseases; Metabolomics; Microbiome; Nutrition; Pediatrics
Abstract
Inflammatory bowel diseases (IBD), including Crohn disease (CD) and ulcerative colitis, affect 1 in 150 Canadians; 25% of cases are diagnosed in children. IBD manifests with chronic gastrointestinal inflammation and altered microbial composition. Dietary changes impact IBD, including the pediatric CD therapy exclusive enteral nutrition (EEN), which entails exclusive intake of liquid meal-replacement, making adherence challenging. Predicting patient outcomes to EEN requires improved understanding of pathogenesis. Our study examines how intestinal microorganisms are involved in IBD development. We hypothesize that an altered intestinal microbiome in response to dietary or bacterial-secreted metabolites mediates patient response to dietary therapy. I will investigate whether previous diet is a valid predictor of EEN success, using metabolomics to develop biomarkers that will identify candidates for EEN success. Pilot analysis of pre-diagnosis food frequency questionnaire (FFQ) data shows that simple carbohydrates and processed meat are predictors of EEN failure and success, respectively. I will expand the analysis to a nation-wide FFQ database, and correlate results with stool microbiome analysis and metabolomics to identify potential mediators. Significantly altered metabolites will be assessed in vitro: gentamicin protection assays and immunofluorescent microscopy will identify effects on bacterial invasion, transepithelial electrical resistance will indicate epithelial barrier integrity changes, and qPCR with Western blotting and ELISA will determine human cell line inflammatory responses. Understanding diet and microbial interactions in pediatric IBD can guide novel therapies and facilitate identification of patients likely to respond to dietary therapies.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dijk, Stephanie I
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~